NIR J BARZILAI, MD
Osteopathic Medicine at Blondell Ave, Bronx, NY
License number
New York 184368
Category
Osteopathic Medicine
Type
Endocrinology, Diabetes & Metabolism
Address
Address
2
1575 Blondell Ave STE 200, Bronx, NY 10461
233 Old Colony Rd, Hartsdale, NY 10530
233 Old Colony Rd, Hartsdale, NY 10530
Phone
(866) 633-8255
(718) 430-3144
(718) 430-8557 (Fax)
(718) 430-3144
(718) 430-8557 (Fax)
Personal information
See more information about NIR J BARZILAI at radaris.comName
Address
Phone
233 Old Colony Rd, Hartsdale, NY 10530
1575 Blondell Ave, Bronx, NY 10461
233 Old Colony Rd, Hartsdale, NY 10530
Professional information
See more information about NIR J BARZILAI at trustoria.com
Dr. Nir J Barzilai, Bronx NY - MD (Doctor of Medicine)
Dr. Nir J Barzilai, Bronx NY - MD (Doctor of Medicine)
Specialties:
Internal Medicine
Address:
1575 Blondell Ave SUITE 200, Bronx 10461
(866) 633-8255 (Phone), (718) 904-2799 (Fax)
BELFER 701C
1300 Morris Park Ave SUITE 701, Bronx 10461
(718) 430-3186 (Phone), (718) 828-6988 (Fax)
(866) 633-8255 (Phone), (718) 904-2799 (Fax)
BELFER 701C
1300 Morris Park Ave SUITE 701, Bronx 10461
(718) 430-3186 (Phone), (718) 828-6988 (Fax)
Certifications:
Internal Medicine, 1995
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
1575 Blondell Ave SUITE 200, Bronx 10461
BELFER 701C
1300 Morris Park Ave SUITE 701, Bronx 10461
Montefiore Medical Center
111 East 210Th St, Bronx 10467
BELFER 701C
1300 Morris Park Ave SUITE 701, Bronx 10461
Montefiore Medical Center
111 East 210Th St, Bronx 10467
Education:
Medical School
Technion-Israel Institute of Technology / Faculty of Medicine
Rambam Hosp
Hebrew U-Hadassah Hosp
Yale U-New Haven Hosp
Albert Einstein Coll Med
Ny Hosp-Cornell U Med Coll
Technion-Israel Institute of Technology / Faculty of Medicine
Rambam Hosp
Hebrew U-Hadassah Hosp
Yale U-New Haven Hosp
Albert Einstein Coll Med
Ny Hosp-Cornell U Med Coll
Nir J Barzilai, Bronx NY
Nir J Barzilai, Bronx NY
Specialties:
Endocrinologist
Address:
111 E 210Th St, Bronx, NY 10467
1575 Blondell Ave, Bronx, NY 10461
1300 Morris Park Ave, Bronx, NY 10461
1575 Blondell Ave, Bronx, NY 10461
1300 Morris Park Ave, Bronx, NY 10461
Education:
Technion - Israel Institute of Technology, Ruth and Bruce Rappaport Faculty of Medicine - Doctor of Medicine
Montefiore Medical Center - Fellowship - Endocrinology
Montefiore Medical Center - Fellowship - Endocrinology
Methods For Determining Likelihood Of Longevity And Of Developing An Age-Related Disease
Methods For Determining Likelihood Of Longevity And Of Developing An Age-Related Disease
US Patent:
2011018, Aug 4, 2011
Filed:
Jan 21, 2011
Appl. No.:
12/930972
Inventors:
Aviv Bergman - New York NY, US
Nir Barzilai - Hartsdale NY, US
Gil Atzmon - New York NY, US
Nir Barzilai - Hartsdale NY, US
Gil Atzmon - New York NY, US
International Classification:
C12Q 1/68
US Classification:
435 611
Abstract:
The present invention provides a method for identifying a subject's likelihood of achieving longevity or of developing an age-related disease, the method for identifying a subject's likelihood of achieving longevity or of developing an age-related disease comprising detecting at least one specified single nucleotide polymorphisms or genotype at a single nucleotide polymorphism or combination of a genotype at a first single nucleotide polymorphism and a genotype at a second single nucleotide polymorphism in a sample of the subject's DNA and, wherein the detection of at least one single nucleotide polymorphisms or genotype at a single nucleotide polymorphism or combination of a genotype at a first single nucleotide polymorphism and a genotype at a second single nucleotide polymorphism identifies the subject's as likely achieving longevity or of developing an age-related disease.
Treatment Of Type 2 Diabetes, Metabolic Syndrome, Myocardial Injury And Neurodegeneration With Humanin And Analogs Thereof
Treatment Of Type 2 Diabetes, Metabolic Syndrome, Myocardial Injury And Neurodegeneration With Humanin And Analogs Thereof
US Patent:
2013004, Feb 21, 2013
Filed:
Oct 9, 2012
Appl. No.:
13/647453
Inventors:
Nir Barzilai - Hartsdale NY, US
Pinchas Cohen - Pacific Palisades CA, US
Radhika Muzumdar - Mamaroneck NY, US
David Lefer - Decatur GA, US
Pinchas Cohen - Pacific Palisades CA, US
Radhika Muzumdar - Mamaroneck NY, US
David Lefer - Decatur GA, US
Assignee:
The Regeants of the University of California - Oakland CA
Albert Einstein College of Medicine of Yeshiva University - Bronx NY
Albert Einstein College of Medicine of Yeshiva University - Bronx NY
International Classification:
A61K 38/17, A61P 3/10
US Classification:
514 69
Abstract:
Provided are methods of using humanin and humanin analogs to treat a mammal exhibiting or at risk for insulin resistance, increase insulin sensitivity in a mammal exhibiting or at risk for insulin resistance, treat type-2 diabetes mellitus, metabolic syndrome, and neurodegeneration, treat and prevent myocardial injury, and determine longevity.
Biological Markers For Longevity And Diseases And Uses Thereof
Biological Markers For Longevity And Diseases And Uses Thereof
US Patent:
2006006, Mar 30, 2006
Filed:
Sep 16, 2005
Appl. No.:
11/229327
Inventors:
Nir Barzilai - Hartsdale NY, US
International Classification:
C12Q 1/68, G01N 33/92
US Classification:
435006000, 436071000
Abstract:
This invention provides methods of using of the sizes and levels of high-density lipoprotein (HDL) and low-density lipoprotein (LDL) particles, the −641 allele of the promoter of the gene encoding apolipoprotein C-3 (APOC-3), the 405 allele of the gene encoding cholesteryl ester transfer protein (CETP), and plasma levels of insulin-like growth factor-1 (IGF-1), adiponectin, CETP and APOC-3, for determining and increasing an individual's likelihood of longevity and of retaining cognitive function during aging, and for determining and decreasing an individual's likelihood of developing a cardiovascular-, metabolic- or age-related disease.
Biological Markers For Longevity And Diseases And Uses Thereof
Biological Markers For Longevity And Diseases And Uses Thereof
US Patent:
8399258, Mar 19, 2013
Filed:
Dec 5, 2008
Appl. No.:
12/315845
Inventors:
Nir Barzilai - Hartsdale NY, US
Assignee:
Albert Einstein College of Medicine of Yeshiva University - Bronx NY
International Classification:
G01N 33/92
US Classification:
436 71
Abstract:
This invention provides methods of using of the sizes and levels of high-density lipoprotein (HDL) and low-density lipoprotein (LDL) particles, the −641 allele of the promoter of the gene encoding apolipoprotein C-3 (APOC-3), the 405 allele of the gene encoding cholesteryl ester transfer protein (CETP), and plasma levels of insulin-like growth factor-1 (IGF-1), adiponectin, CETP and APOC-3, for determining and increasing an individual's likelihood of longevity and of retaining cognitive function during aging, and for determining and decreasing an individual's likelihood of developing a cardiovascular-, metabolic- or age-related disease.
Treatment Of Type 2 Diabetes, Metabolic Syndrome, Myocardial Injury And Neurodegeneration With Humanin And Analogs Thereof
Treatment Of Type 2 Diabetes, Metabolic Syndrome, Myocardial Injury And Neurodegeneration With Humanin And Analogs Thereof
US Patent:
8309525, Nov 13, 2012
Filed:
May 28, 2008
Appl. No.:
12/451524
Inventors:
Nir Barzilai - Hartsdale NY, US
Pinchas Cohen - Pacific Palisades CA, US
Radhika Muzumdar - Mamaroneck NY, US
Pinchas Cohen - Pacific Palisades CA, US
Radhika Muzumdar - Mamaroneck NY, US
Assignee:
Albert Einstein College of Medicine of Yeshiva University - Bronx NY
The Regents of the University of California - Oakland CA
The Regents of the University of California - Oakland CA
International Classification:
A61K 38/16, A61K 38/17
US Classification:
514 214, 514 67, 514 68, 514 69, 514 213
Abstract:
Provided are methods of using humanin and humanin analogs to treat a mammal exhibiting or at risk for insulin resistance, increase insulin sensitivity in a mammal exhibiting or at risk for insulin resistance, treat type-2 diabetes mellitus, metabolic syndrome, and neurodegeneration, treat and prevent myocardial injury, and determine longevity.